The pharmaceutical industry is changing and manufacturers need to modify approaches and structures to survive in a competitive environment. The pace of change necessitates that Pharmaceutical companies undergo a transformation; with organizations expanding the capabilities of their commercial models through smarter experimentation, scalable measurement, faster learning, and dynamic decision making.
A transformation of this nature is not necessarily easy to implement. Pharmaceutical manufacturers must experiment and adapt their commercial models to overcome barriers to growth. Corporate cultures, infrastructure, and established processes need to be reviewed, evaluated, and perhaps modified. This white paper discusses the challenges and potential approaches around creating a “continuously experimenting, continuously learning, continuously adapting” organization.